Skip to content

Author

Nirvana A. Gohar

We have 3 of 19 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Discovery of New Pyrazole‐Linked Pyridine Derivatives as Multi‐Target Anti‐Inflammatory Agents With Immunomodulatory Potential

Cyclooxygenase (COX) plays a crucial role in the inflammatory response, making selective COX‐2 inhibition a significant strategy for developing safer anti‐inflammatory medications. Accordingly, developing new pharmacotherapies is a critical objective in anti‐inflammatory drug discovery. In this study, a new pyrazole‐li...

Mohamed A. Salem, Reham R Raslan, Nirvana A. Gohar et al. · 0 citations
Sep 2026

Cyanopyridine-based derivatives as potent anticancer agents: Integrating in silico analysis and in vitro biological targeting of the EGFR/AKT/MAPK Signaling Cascade.

The increasing global incidence of cancer and the recurrent development of resistance to standard treatments require a rapid development of innovative, multi-targeted chemotherapeutic medicines. This study focused on the strategic design and synthesis of a range of new cyanopyridine derivatives (1a,b-5a,b) targeting th...

Shimaa M. Alhamaky, Marwa S. A. Hassan, Eman M. Ahmed et al. · 0 citations
Jul 2026

Insights into novel benzo[h]quinoline-based 2-thioxothiazolidin-4-one and thiazol-4-one hybrids as potential antimicrobial, and antibiofilm candidates: Design, synthesis, molecular modeling, and in-silico ADME studies.

The findings strongly confirm the substituted benzo[h]quinoline core as a highly promising pharmacophore for the development of next-generation antimicrobial medicines effective against both free-floating planktonic cells and tough structured biofilms.

Reham R Raslan, S. Eissa, Moustafa S. Abusaif et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.